CIK 0001664710 · Non-accelerated filer<br>Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811173868
- Phone
- 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- DEFA14A Proxy Proxy Materials
- S-8 Other Securities Offered to Employees in Benefit Plans
- POS EX Other Post-effective Amendment
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- DRS Other Draft Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
- CERT Other Certification
- 8-A12B Other Registration of Securities
- D Other Notice of Sales of Unregistered Securities
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- D Other Notice of Sales of Unregistered Securities
Page 3 of 3 · 59 filings